Ad
related to: dr reddy's labs
Search results
Results from the WOW.Com Content Network
Dr. Reddy's Laboratories is an Indian multinational pharmaceutical company based in Hyderabad. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. [2]
Kallam Anji Reddy. Kallam Anji Reddy (10 August 1941 – 15 March 2013) was an Indian entrepreneur in the pharmaceutical industry, the founder-chairman of Dr. Reddy's Laboratories, which he established in 1984, and chairman of Dr Reddy's Foundation (DRF), the corporate social responsibility arm of the group, established 1996.
Kallam Satish Reddy. Kallam Satish Reddy is an Indian business executive and current Chairman of Dr. Reddy's Laboratories. [2] [3] Reddy joined Dr. Reddy's Laboratories in 1993 as executive director. Elevated to the role of Managing Director in 1997, he led the company's transition from a manufacturer of active pharmaceutical ingredients to one ...
Dr. Reddy's Laboratories (NYS: RDY) reported earnings on May 11. Here are the numbers you need to know. The 10-second takeawayFor the quarter ended March 31 (Q4), Dr. Reddy's Laboratories beat ...
Dr. Reddy's Labs quotes IMS Health in noting the branded drug had domestic sales of approximately $300.5 million for the trailing 12-month period ending in April.
Let's take a quick look at three stocks -- Dr. Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're ...
Kallam Satish Reddy (brother-in-law) G. V. Prasad ( Telugu: జి.వి. ప్రసాద్) is an Indian business executive, and co-chairman and managing director of Dr. Reddy's Laboratories. [1] He studied chemical engineering at the Alagappa College of Technology. After completing five semesters, Prasad went on to the Illinois Institute ...
In 2022, Mankind acquired Panacea Biotec Pharma 's domestic formulations brands in India and Nepal for ₹1,872 crore (US$220 million). [25] It then acquired a respiratory treatment product, and an infant skincare brand from Dr. Reddy's Laboratories. [26]
On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG. On 21 February, 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age.
On 19 May 2021, Dr Reddy's Labs received Emergency Use Authorisation for anti-COVID drug 2-DG. On 21 February, 2022, Drugs Controller General of India granted approval to Biological E's COVID-19 vaccine Corbevax, that can be used for children between 12 and 18 years of age.